Becker's Healthcare January 16, 2025
The Drug Enforcement Administration and HHS have published a final rule to allow providers to prescribe buprenorphine through telehealth.
In a final rule published Jan. 15, the agency said it would allow providers to prescribe up to a six-month supply of buprenorphine through telehealth, without seeing a patient in person first.
The agency also published a proposed rule Jan. 15 regulating the prescribing of other controlled substances via telehealth. The agency first implemented rules allowing providers to dispense controlled substances through telehealth during the COVID-19 pandemic. Current flexibilities are in place through the end of 2025.
In September, hundreds of healthcare organizations, including the American Psychiatric Association and other mental health groups, urged the DEA to keep...
Today's Sponsors
Today's Sponsor